Resources>Citations Database>Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation

Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation

Biointron 2019-07-29

Authors: Jingyu Li, Wenli Shi, Hanxiao Sun, Yan Ji, Yuqin Chen, Xiaohuan Guo, Huiming Sheng, Jie Shu, Liang Zhou, Ting Cai, and Ju Qiu

Journal: Nature Communications

PubMed ID: 31358760

DOI: https://doi.org/10.1038/s41467-019-11304-8

Products & Services: DR3-Fc (a synthesized decoy receptor for TL1A by expression of DR3 conjugated with mouse-Fc) was synthesized by Biointron

Subscribe to our Citations Database
Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.